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                                                   INTRODUCTION
MR spectroscopy provides a measure of brain chemistry. The most common nuclei that 
are  used  are 1H (proton), 23Na (sodium), 31P (phosphorus). Proton  spectroscopy  is  easier  to 
perform and provides much higher signal-to-noise than either sodium or phosphorus. Magnetic 
resonance spectroscopy (MRS) has received little attention from the neurosurgeons because 
the results are obtained in graphs, not in pictures and until lately it required dedicated units and 
software. 
Adequate MR Spectra may be obtained in periods of time as short as 10 to 15 minutes. 
Therefore,  they  may  be  added  to  routine  MR  imaging  studies  without  significant  time 
penalties. The MR spectra do not come labeled with the diagnosis. They require interpretation 
and should always be correlated with the MR images before making a final diagnosis. More 
over, MR spectroscopy provides greater information concerning tissue characterization than 
what  is  possible  with  MR imaging  studies  alone.  We  evaluated  the  utility  of  proton  MR 
Spectroscopy  in  differentiating  intracranial  tumors  with  emphasis  on  differentiating  ring 
enhancing lesions of the brain.
MR imaging  has  made  it  easier  to  detect  and  distinguish  among  intracranial  mass 
lesions.  Nevertheless,  in some cases it  is  impossible to base a specific diagnosis solely on 
clinical and radiological findings. Thus biopsy has to be performed to provide a diagnosis as 
the basis for treatment regimens. Open biopsy is commonly used, and if possible, combined 
with open resection of the intracranial tumor. Lesions located in vital or eloquent parts of the 
brain, however, may be unsuitable for open neurosurgical intervention.
MR  spectroscopy  (MRS)  is  a  technique  that  allows  noninvasive  monitoring  of 
metabolites within the tissue of interest, and has the potential for providing information about a 
lesion’s  composition  and response to  therapy.  A number  of  water-suppressed proton  (1H) 
MRS techniques have been developed for obtaining spectra from selected regions within the 
brain. These provide either a single-spectrum (single-voxel MRS) or a multidimensional array 
of spectra from the region of interest (multivoxel MRS imaging).
The purpose of this study was to evaluate the hypothesis that proton MR spectroscopy 
might be able to improve preoperative diagnostic accuracy in patients scheduled for biopsy of 
intracranial mass lesions and therefore obviate biopsy in some cases.
BASICS OF MAGNETIC RESONANCE SPECTROSCOPY
Spectroscopy based on nuclear magnetic resonance is used for analysis of molecules. 
MRS is a method to obtain NMR information regarding biochemical substances such as ATP, 
choline, lactic acid in vivo by collecting magnetic resonance signals from nuclei of biological 
substances such as P31 and H1  other than water and fat. Therefore, MRS provides molecular 
based  information  such  as  that  concerning  biochemical  changes  in  the  body,  unlike 
histomorphological information derived from MRI.
RF COIL
Special radio frequency coils designated to measure different parts of the body are used 
to allow the corresponding area to generate magnetic resonance signals and to receive them. In 
this evaluation, MRS is performed using H1 as the nuclei.  When MRS is performed using 
nuclei  other  then  H1 like  P31,  special  frequency  hardware  becomes  necessary  because  of 
difference in  the  resonance frequency.  To obtain spectra  signals,  H1 MR images  must  be 
obtained in advance and the region in which measurements are made must be targeted. The 
patients here are carefully immobilized to obtain high reproducibility.
LOCALISATION
Biochemical activities in the body occur unevenly at the microscopic level and different 
tissues e.g., normal tissue and malignant tissue exhibit different biochemical activities.
Without localizing the area in which magnetic resonance signals are to be collected, a 
variety of biochemical activities will commingle. Therefore, selection of the region in which 
signals are to be obtained is one of the keys to successful MRS. There are several methods for 
restricting signal reception. The use of surface coil, the three dimensional localization method 
by  adding  the  positional  information  to  the  magnetic  resonance  signals  using  gradient 
magnetic field similar to that used in MRI is the one that is commonly employed. This three 
dimensional  localizing  method  can  be  classified  into  single  voxel  spectroscopy,  in  which 
single  region is  excited selectively and multi  voxel  method,  in  which magnetic  resonance 
spectra are examined from multiple voxels in a matrix.
SINGLE VOXEL METHOD
This method is a technique that makes a specified selected signal generate second spin 
echo. This method is otherwise called point resolved spectroscopy (PRESS). Radiofrequency 
pulse in a sequence of 90o – 180o – 180o induces two spin echoes. Since the slice-selective 
gradient  magnetic  fields  corresponding  to  each  radiofrequency  pulse  are  different,  three 
perpendicular  planes  are  usually  selected.  As  a  result,  the  part  in  which  the  three  planes 
converge becomes the selected region since the second spin echo is generated selectively in 
this region. The second spin echo region in which selected slices of three gradient magnetic 
fields intersect with one another is taken as the region selected for MRS. Also, the gradient 
magnetic fields applied before and after the timing of each 180o pulse to cancel the phase of 
spins other than those in the selected region are called spoiled gradient magnetic fields.  Since 
the phase of spins in the selected region are reversed by 180o pulses,  the phases of  spins 
induced by spoiled gradient magnetic fields before and after the 180o pulse cancel and the 
signal is preserved.
STEAM (Stimulated Echo-Acquisition Mode)
This  technique  is  used  to  induce  stimulated  echo  signals  exclusively  from a  given 
region. Stimulated echoes are generated by a sequence of 90o – 90o – 90o signals. Stimulated 
echo is  different from spin echo in that,  instead of 180o pulse,  it  employs two 90o pulses 
sandwiching the mixing time. Since the mixing time is independent, time to echo  can be made 
relatively  short.  Therefore,  compared  with  press,  the  time  from  initial  excitation  to  the 
generation of signal echoes can be reduced for measurement of metabolites with short T2.
The  stimulated  echo  is  explained  qualitatively  as  follows.  The  phases  of  the  spins 
induced by the first 90 o  pulse are distributed  isotropically due to T2 relaxation and spoiling 
gradient magnetic fields. After the second 90 o pulse, half the information of the excited spins is 
preserved in the direction Bo (the z axis). Finally the preserved spin is transferred to the  xy 
plane by the third 90 o  pulse and a stimulated echo is generated after TE similar to the spin 
echo.  Since  only  half  the  information  of  the  induced  spin  could  be  obtained,  the  signal 
intensity  is  smaller than in PRESS with a similar  delay time.   While two 180o pulses are 
employed  in  PRESS,  the  pulses  used  in  STEAM  are  all  90 o.  In  addition  the  regional 
selectivity is higher with 90 o  pulses. This is a major feature of STEAM. By contrast, the flip 
angle of 180o pulses used in PRESS must be carefully adjusted and radiofrequency coils with 
homogenous radiofrequency magnetic field are required.
MULTI VOXEL METHOD
The  single  voxel  method  provides  information  in  only  single  selected  region.  The 
multivoxel  method  is  used  to  simultaneously  obtain  spectra  in  multiple  regions.   In  this 
method,  the given field of  view (FOV) is  divided into several  voxels  and the spectrum is 
examined in each voxel. In this method, the number of voxels is relatively small compared 
with MRI, but the method is also called chemical shift imaging (CSI) because it is a variation 
of MRI.
As a  general  rule,  the  single  voxel,  short  TE technique  is  used  to  make the  initial 
diagnosis, because the signal-to-noise is high and all metabolites are represented. Multi voxel, 
long TE techniques are used to further characterize different regions of a mass and to assess 
brain parenchyma around or adjacent to the mass. Multi-voxel, long TE techniques are also 
used to assess response to therapy and to search for tumor recurrence.
SATURATION AND RELAXATION
The transition of nuclear spins into the hierarchical equilibrium state in the presence of 
an external  magnetic field is  not  instantaneous but rather is  governed by a first-order  rate 
process.  Once  a  nucleus  reaches  a  higher  energy  state  whether  it  is  due  to  the  external 
magnetic field or an RF pulse, there would be no further absorption of energy and soon the 
population difference between the two states would be zero. The system would thus reach 
saturation. 
 The only way the nuclei can remain accessible to further energy absorption is by a 
mechanism of energy emission or loss. Nuclei do not collide easily and therefore, cannot lose 
energy  as  molecular,  vibration,  or  translational  loss.  Nuclei  lose  their  energy  through 
resonance with the molecular motion of the lattice. Rotational and translational motions of 
molecules in liquids create fluctuating time-dependent magnetic fields. When the frequency of 
this fluctuating magnetic field equals the Larmor frequency, a magnetic torque is exerted to 
flip the orientation of the nuclei and thus their energy states. The magnetic energy received by 
the lattice is transferred into thermal energy. 
Since this  process of  energy loss  or  relaxation is  quite  dependent  on the  molecular 
environment, different molecular environments encountered for H1 will yield different rates of 
relaxation governed by their  relaxation time,  T1.  Thus,  gray and white matter  would have 
different rates of recovery of protons in the longitudinal plane.
The  time  dependence  of  the  magnetization  in  the  transverse  plane  after  the  RF 
resonance is affected by another relaxation time, i.e., the spin–spin relaxation time, T2. As in 
the case of spin–lattice relaxation, the local fluctuating magnetic field due to the molecular 
motion also affects T2. 
The phase coherence of the individual nuclear spins when exposed to the fluctuations 
along with  the  inhomogeneities  in  the  external  magnetic  field  results  in  a  spread of  their 
Larmor frequencies seen as a “fanning out” or loss of phase after which the spins move back to 
the axis of the external field as magnetization in the transverse plane goes to zero. This type of 
relaxation is different from longitudinal relaxation since the total energy of the spin system 
does not change.
THE CHEMICAL SHIFT
Earlier  it  was  stated  that  the  resonance  frequency  for  nuclei  is  dependent  on  the 
magnetic  field  experienced  by  the  nuclei.  One  would  hence  expect  the  same  nuclei  in  a 
compound to resonate at a single frequency. This, however, was found not to be the case soon 
after  the  discovery  of  NMR.  Even a  pure  compound  such  as  ethanol  was  found  to  have 
multiple frequency peaks. 
Since the external magnetic field was homogeneous within the liquid, the explanation 
laid in differences in microscopic magnetic environments within the molecules as a result of 
which nuclei experienced variations in the effective magnetic field. These microscopic field 
variations arise from the electrons orbiting the nucleus and producing their own weak magnetic 
field. The s-electrons are spherically symmetric and circulate producing current, which in turn 
produces a magnetic field at the nucleus, which opposes the external magnetic field. 
Thus, in order to obtain the resonance condition, it is necessary to increase the applied 
field over that for the isolated nucleus. If one nucleus is more shielded than another in the 
same external field, its signal will be shifted to a lower frequency. Because the strength of the 
induced field due to nuclear shielding is proportional to that of the applied field, we can define 
a  constant,  called  the  shielding  or  screening  constant,  which  is  sensitive  to  the  chemical 
environment of the nuclei. 
Therefore,  nuclei  in different  chemical  environments experience different fields and 
hence produce signals at different frequencies. This up field shift of the nucleus is called a 
diamagnetic shift and is present in every molecule since each has s-electrons. The electrons in 
p-orbit  with  no  spherical  symmetry  produce  magnetic  fields  that  are  large  which  when 
averaged over molecular motion give low-field shifts.  This deshielding effect  is  called the 
paramagnetic shift. Of course, for protons with no p-electrons there is no paramagnetic term. 
Thus,  the  practical  implication  is  that  the  differences  in  the  resonance  frequencies 
between  different  nuclei  range  in  millions  of  hertz  (Hz)  and  the  spread  of  resonance 
frequencies for a single nucleus is in the range of a few thousands of hertz due to this chemical 
shift. The electronic screening is due not only to the electrons from the nucleus’ own electronic 
cloud but also to differences in chemical  bonds between various atoms and their  different 
electron distributions. 
Thus, hydrogen bonded to carbon experiences a different "electron field" than hydrogen 
bonded  to  oxygen.  In  addition,  the  types  of  bonds  (single,  double)  influence  the  field. 
Spectroscopy is then this extraction of the shift in frequencies from the NMR signal, which 
clues one to shifts or differences in the molecular structure of tissues. While the chemical shift 
may introduce artifacts in NMR imaging; it is the basis of spectroscopy.
In this way, the chemical shift is normalized with respect to the operating frequency and 
is independent of the external magnetic field, making comparison of data easy and simple.
WATER SUPPRESSION
In proton MRS, the amount of  H1 in water is  overwhelmingly greater than that  of 
metabolites such as lactic acid and NAA. Therefore magnetic resonance signals from H1 in 
water must be suppressed. 
CHESS (Chemical Shift Selective) is a method used to achieve this. This sequence is 
placed above the pulse sequence for localization of the nuclei. In this sequence suppression of 
radiofrequency pulse has narrow resonance frequency of water and has a narrow band that 
does not overlap the frequency of H1 in each metabolite. A gradient magnetic field follows the 
suppression of radiofrequency pulse to cancel out the direction of the spins.
Selective T1 Relaxation
An inversion recovery scheme can be used for water suppression since the water T1 
may be significantly different from other metabolites. The magnetization is first inverted with 
a 180° pulse. After a time, the longitudinal magnetization recovers. The water magnetization is 
null at a time when other molecules are partially or completely relaxed and the sampling pulse 
can be generated. This sequence, however, has the drawback of requiring long TD since water 
T1 is long. In addition, it  is  also difficult  to quantitate since the metabolites  may be only 
partially relaxed.
RECEPTION OF SIGNALS AND RF DETECTION
After the radio frequency signals from various substances,  including the metabolites 
with  different  resonant  frequencies  according  to  the  differences  in  the  chemical  shift  are 
received with a radiofrequency coil, they are amplified by a preamplifier and detected as low 
frequency components by two phase detectors. 
Detection occurs by picking a lower frequency from the entire frequency by eliminating 
the  reference  radiofrequency  of  the  apparatus.  In  a  1.5  Tesla  MRI  with  a  standard 
radiofrequency of 64 MHz, the bandwidth of signals detected is usually 640 Hz or less because 
the spectral band of H1 MRS is about 10ppm. This conversion to a lower frequency allows 
analogue-digital conversion of signals and the data can be processed by a computer.
DATA PROCESSING
After the FID is collected in the time domain, it needs to be conditioned, corrected, and 
transformed  into  the  frequency  domain  to  see  the  chemical  shift  of  the  metabolites.  This 
transformation is brought about by a mathematical operation called Fourier transformation.
Zero Filling
Some manipulations are done to the FID in the time domain before performing Fourier 
transformation. It is preferable to increase the number of complex data points by a technique 
called zero filling. It consists of extending the experimental time domain data set by a number 
of  zeroes.  This  has  a  similar  effect  as  increasing the  sampling points  after  the  signal  has 
decayed. It results in a smooth interpolation between the spectral data points and improves the 
appearance of the spectrum after Fourier transformation
Apodization
Apodization  means  "cutting  the  feet  off."  It  indicates  a  mathematical  operation  by 
which all of the data points of the FID are multiplied by a function characterized by a starting 
value of 1 and that decays regularly to zero at the end of the acquisition time.
OBSERVED METABOLITES AND THEIR SIGNIFICANCE
There  is  evidence  that  the  concentration  of  normal  metabolites  in  the  brain  varies 
according to the patient’s age. This variation is more noticeable during the first 3 years of life 
but may be seen up to 16 years of age. The most striking variation is an increase in NAA/Cr 
ratio  and a  decrease  in  the  Cho/Cr  ratio  as  the  brain matures.  These  changes  may reflect 
neuronal maturation and an increase in the number of axons, dendrites, and synapses. 
N-Acetyl-L-aspartate (NAA)
The presence of NAA is attributable to its  N-acetyl methyl group, which resonates at 
2.0ppm. This peak also contains contributions from less important  N-acetyl groups. NAA is 
accepted as a neuronal marker, its concentration will decrease with many insults to the brain.31 
The  role  of  NAA  in  the  brain  is  unknown.  N-Acetyl-aspartyl-glutamate  (NAAG)  is  co 
localized with NAA in neurons and releases NAA and glutamate when it is cleaved by  N-
acetylated alpha-linked dipeptidase.39 Breakdown  of  N-acetyl-aspartyl  glutamate  releases 
both  NAA  and  glutamate  and  subsequent  breakdown  of  NAA  leads  to  aspartate.  These 
compounds are excitatory amino acids and are increased with ischemia. NAA is not present in 
tumors outside the central nervous system. In normal spectra, NAA is the largest peak.
Choline (Cho)
The  peak  for  Choline  occurs  at  3.2  ppm.  It  contains  contributions  from 
glycerophosphocholine, phosphocholine, phosphatidylcholine and therefore reflects total brain 
choline stores. Choline is a constituent of the phospholipid metabolism of cell membranes and 
reflects membrane turnover, and it is a precursor for acetylcholine and phosphatidylcholine. 
Acetylcholine is a neurotransmitter that is critical for many aspects of memory, cognition, and 
mood.
Creatinine (Cr)
The peak for Cr is seen at 3.03 ppm and contains contributions from Cr, Cr phosphate, 
and, to a lesser degree,  gamma-amino butyric acid, lysine, and glutathione.23 An additional 
peak for Cr may be visible at 3.94 ppm. Therefore, the Cr peak is sometimes referred to as 
“total Cr.” Cr probably plays a role in maintaining energy-dependent systems in brain cells by 
serving as a reserve for high energy phosphates and as a buffer in adenosine triphosphate and 
adenosine diphosphate reservoirs. Cr is increased in hypo metabolic states and decreased in 
hyper metabolic states. In normal spectra, Cr is located to the immediate right of Cho and is 
the third-highest peak. Because this peak remains fairly stable even in face of disease, it may 
be used as a control value.
Lactate
The lactate  peak has  a  particular  configuration.  It  consists  of  two distinct,  resonant 
peaks called a “doublet” and is caused by the magnetic field interactions between adjacent 
protons (J coupling). This lactate doublet occurs at 1.32 ppm. A second peak for lactate occurs 
at  4.1 ppm. Because this latter peak is  very close to the water,  it  is  generally suppressed. 
Normally lactate levels in the brain are low. The presence of lactate generally indicates that the 
normal cellular oxidative respiration mechanism is no longer in effect, and that carbohydrate 
catabolism is  taking  place.40 Lactate  can  play  a  role  as  a  neuromodulator  by  altering  the 
excitability of local neurons.
Myoinositol
Myoinositol  is  a  metabolite  involved  in  hormone  sensitive  neuroreception  and  is  a 
possible  precursor  of  glucuronic  acid,  which  detoxifies  xenobiotics  by  conjugation.48 The 
myoinositol peak occurs at 3.56 ppm.
Glutamate and Glutamine
Glutamate  is  an  excitatory  neurotransmitter  which  plays  a  role  in  mitochondrial 
metabolism. Gamma-amino butyric acid is an important product of glutamate. Glutamine plays 
a role in detoxification and regulation of neurotransmitter activities.30 These two metabolites 
resonate closely together and they are commonly represented by their sum as peaks located 
between 2.1 and 2.5 ppm. 
Alanine
Alanine  is  a  nonessential  amino  acid  whose  function  is  uncertain.  Its  peak  occurs 
between 1.3 and 1.4 ppm and therefore may be overshadowed by the presence of lactate. 
Lipids
Membrane lipids in the brain have very short relaxation times and are normally not 
observed unless very short TEs are used. The protons of lipids produce peaks at 0.8, 1.2, 1.5 
and 6.0  ppm.6 These  peaks  comprise  methyl,  methylene,  allelic,  and  the  vinyl  protons  of 
unsaturated fatty acids. These metabolites may be increased in high-grade astrocytomas and 
meningiomas and may reflect necrotic processes. However, it is also important to remember 
that normal lipid resonances arising from fat may be the result of voxel contamination by fat 
located in the subcutaneous scalp.
CLINICAL APPLICATIONS OF MRS IN NEUROSURGERY
Astrocytomas
Proton  MR  Spectroscopy  readily  distinguishes  normal  brain  tissues  from 
astrocytomas.5,13,26 However, proton MR spectroscopy may not be able to distinguish between 
different histological grades of malignancy in astrocytomas. Some investigators have proposed 
that  the  presence  of  lactate  correlates  with  a  higher  degree  of  malignancy  and  that  it  is 
commonly observed in glioblastoma multiforme.10,12
 The  typical  Proton  MR  Spectroscopic  characteristics  of  astrocytomas  include  a 
significant reduction in NAA, a moderate reduction in Cr, and an elevation of Cho. Reduction 
of NAA probably indicates a loss of normal neuronal elements as they are destroyed and/or 
substituted by malignant cells. In astrocytomas, the NAA is reduced to 40% to 70% of that in 
normal brain. Reduction of Cr is probably related to an altered metabolism, and elevation of 
Cho may reflect increased membrane synthesis and cellularity (both of which are present in 
tumors). Elevation of lactate may reflect tumor hypoxia. The Cho peak also is increased in the 
malignant astrocytomas. MR spectroscopy may be used to distinguish infection from a tumor, 
because the former has extremely low concentrations of Cho. Proton MR Spectroscopy may 
also play a role in monitoring the response of astrocytomas to treatment. In some instances, 
proton MR spectroscopy may detect tumor recurrence before MR images become abnormal.
Differentiation  between  gliomatosis  cerebri  and  low  grade  glioma  on  anatomical 
grounds  is  difficult.  There  are,  however,  subtle  MRS  variations  which  may  be  helpful. 
Gliomatosis  cerebri  shows  increased  levels  of  creatine  compared  to  low  to  normal 
concentration in low grade glioma. There are no significant differences in levels of Cho, NAA 
and myoinositol.
Metastases
In  adults  with  multiple  brain  lesions  the  primary  differential  diagnosis  is  that  of 
metastases. In the presence of a single lesion, differentiating between primary and secondary 
brain tumors is important but not often possible.24,35 Metastases commonly show moderate to 
marked reduction of NAA, a decreased Cr signal, and elevated Cho. 
These  features  are  identical  to  those  present  in  astrocytomas.  Some  metastases 
(particularly those from breast carcinomas41) may also contain lipids. Lipid resonance may also 
be present in high grade astrocytomas and is caused by the presence of necrosis.
Radiation Injury
Histologically, radiation injury is characterized by damage to the vascular endothelium 
that  may  result  in  ischemia  and  necrosis.  MR spectroscopy  shows  elevation  of  lactate  in 
patients who have received 40 Gy or more to the brain. This abnormality is appreciable even 
when  the  MR  imaging  studies  are  normal.  Therefore,  proton  MR  spectroscopy  may  be 
promising as a tool for the detection of radiation injury before it  becomes evident by MR 
imaging. Radiation necrosis may be indistinguishable from residual and recurrent tumors by 
computed tomography. 
Patients with radiation necrosis showed highly depressed levels of NAA, Cho, and Cr 
and an intense and broad peak between 0 and 2.0 ppm. This peak is consistent with tissue 
necrosis. This cellular breakdown peak probably consists of free fatty acids, lactate, and amino 
acids. Elevated lactate, reflecting severe tissue ischemia and/or mitochondrial damage, will be 
present in these patients.14
Meningiomas
Because meningiomas arise outside the central nervous system, theoretically they do not 
contain NAA.  The  signal  of  Cho is,  however,  markedly  increased  (up  300 times  normal) 
particularly  in  recurrent  meningiomas.  Lactate  and  alanine  may  be  also  elevated  in  some 
meningiomas. There is no clear explanation for the increase in alanine in meningiomas. The 
above proton MR spectroscopic features are seen in typical meningiomas (fibrous type). 
Multiple Sclerosis
MR images with contrast will show enhancement in active multiple sclerosis lesions. It 
has been shown that NAA is decreased in patients with chronic multiple sclerosis in whom 
axonal loss has occurred. Conversely, in acute plaques, NAA may be normal, indicating that 
the  axons  have  not  yet  disappeared  or  have  been  permanently  damaged.1,2 In  addition, 
resonances  corresponding  to  free  lipids  (0.9  to  1.6  ppm)  have  been  observed  in  chronic 
multiple sclerosis plaques and may reflect disintegration of myelin.
Infections
Brain abscesses typically show reduced levels of Cho, NAA and Cr. MRS can be used 
to  distinguish  pyogenic  from tuberculous  brain  abscess. Pyogenic  abscesses  usually  show 
increased amino acid (valine, leucine, isoleucine) peaks due to prominent proteolysis, while 
tuberculous abscess predominantly gives a lipid peak. Intracranial tuberculoma shows lipid 
resonance at 1.3 ppm, 2.02 ppm, and 3.7 ppm at in vivo MR spectroscopy.16
REVIEW OF LITERATURE
Several studies have been published regarding the use of proton magnetic resonance 
spectroscopy  in  characterization  of  brain  tumors.  But  only  few  studies  are  available  in 
distinguishing the ring enhancing lesions of the brain with MRS.
Classification of brain tumors using short echo time 1H MR Spectra:
Devos A, Lukas L et al 11
The purpose was to objectively compare the application of several techniques and the 
use  of  several  input  features  for  brain  tumor  classification  using  Magnetic  Resonance 
Spectroscopy (MRS). The area under the receiver operating characteristic curve (AUC) was 
used  to  measure  the  performance  of  binary  classifiers,  while  the  percentage  of  correct 
classifications was used to evaluate the multi class classifiers. The influence of several factors 
on the classification performance has been tested: L2- vs. water normalization, magnitude vs. 
real  spectra  and baseline  correction.  Using L2-normalized complete  spectra  the  automated 
binary classifiers reached a mean test AUC of more than 0.95, except for glioblastomas vs. 
metastases.  This  indicates  that  data  acquisition  and  processing  can  be  simplified  for 
classification  purposes,  excluding  the  need  for  separate  water  signal  acquisition,  baseline 
correction and phasing.
Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical 
grade of pediatric brain tumors:
Astrakas LG et al
This study evaluated the proton magnetic resonance spectroscopic imaging exams for 
66  children  with  brain  tumors.  Neuro  pathological  grading  was  done  with  WHO criteria. 
Normalized Cho and lipids and/or lactate were elevated in high-grade (n = 23) versus low-
grade (n = 43) tumors,  which were confirmed by means of multiple logistic regression as 
independent  predictors  of  tumor  grade.  Proton  magnetic  resonance  spectroscopic  imaging, 
although not a proxy for histology, provides noninvasive, in vivo biomarkers for predicting 
clinical grades of pediatric brain tumors.
Automated classification of  short  echo time in vivo 1H brain tumor spectra:  a  multi 
center study:
Tate AR, Majós C et al 45
Automated pattern recognition techniques are needed to  help radiologists  categorize 
MRS data of brain tumors according to histological types and grades. A subset of 144 histo 
pathologically validated brain tumor spectra in the INTERPRET database, obtained from three 
of the collaborating centers,  were grouped into meningiomas,  low-grade astrocytomas,  and 
"aggressive tumors" According to this study pattern recognition algorithms were less sensitive 
to acquisition parameters than had been expected.
1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast 
spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence:
Träber F et al. 46
54 patients with malignant brain tumor (44 cases of glioblastoma, 10 other high-grade 
gliomas) were examined post-surgically in a total of 140 proton MRS examinations in the 
course  of  radiotherapy  and  in  follow-up  controls.  In  all  these  cases  MRS diagnosis  was 
confirmed histologically or by short-term follow-up. However, in 6 of 15 patients showing a 
normal choline pattern in the TSI acquisition, tumor recurrence appeared within three months. 
SVS provided early recognition of recurrent tumor when detecting characteristic alterations of 
metabolite concentrations in therapy follow-up. 
Histopathological  validation  of  a  three-dimensional  magnetic  resonance  spectroscopy 
index as a predictor of tumor presence:
McKnight TR et al 29
This study was done by comparing data obtained preoperatively from proton magnetic 
resonance spectroscopy with the results of histopathological assays of tissue biopsies obtained 
during surgery to verify the sensitivity and specificity of a choline-containing compound-N-
acetylaspartate index (CNI), which was used to distinguish tumor from nontumorous tissue 
within  T2-hyperintense  and  contrast-enhancing  lesions  of  patients  with  untreated  gliomas. 
Biopsy  samples  containing  tumor  were  distinguished  from  those  containing  a  mixture  of 
normal, edematous, gliotic, and necrotic tissue with 90% sensitivity and 86% specificity by 
using a CNI threshold of 2.5. On an average, one third to one half of the T2-hyperintense 
lesion outside the contrast-enhancing lesion contained CNI greater than 2.5.
Correlation  of  magnetic  resonance  spectroscopic  and  growth  characteristics  within 
Grades II and III gliomas;
McKnight TR at al 28
In  this  study,  patients  with  presumed  Grades  II  or  III  glioma  underwent  3D  MR 
spectroscopic  imaging  prior  to  surgery,  and  two  or  three  regions  within  the  tumor  were 
targeted for biopsy retrieval based on their spectroscopic features. The authors found that the 
relative  levels  of  Cho and N-acetylaspartate  (NAA) correlated  with  the  cell  density..  The 
association was stronger in tumors with large ranges of Cho/NAA values, irrespective of the 
presence  of  contrast  enhancement.  The  findings  demonstrate  the  validity  of  using  MR 
spectroscopy to identify regions of aggressive growth in presumed Grade II or III gliomas that 
would be suitable targets for retrieving diagnostic biopsy specimens.
Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy 
in the differential diagnosis of ring-enhancing intracranial cystic mass lesions:
Mishra AM at al
In this study apparent diffusion coefficient values in 21 patients with abscesses were 
observed within the range of defined criteria, whereas in 8 patients, ADC values were beyond 
the range of defined criteria. Lactate and AAs with or without other metabolites were observed 
in 25 of 29 cases of abscesses on PMRS. Demonstration of restricted diffusion on DWI with 
reduced ADC is highly suggestive of brain abscess; however, in the absence of restriction, 
PMRS is mandatory to distinguish brain abscesses from cystic tumors.
Clinical  application  of  proton  magnetic  resonance  spectroscopy  in  the  diagnosis  of 
intracranial mass lesions:
Möller-Hartmann W et al 33
This study was done to evaluate the clinical utility of 1H-MRS added to MRI for the 
differentiation  of  intracranial  neoplastic  and  non-neoplastic  mass  lesions.  176  mostly 
histologically verified lesions were studied with a constant clinically available single volume 
1H-MRS protocol following routine MRI. This study shows that spectroscopy added to MRI 
helps in tissue characterization of intracranial mass lesions, thereby leading to an improved 
diagnosis of focal brain disease.
Proton  magnetic  resonance  spectroscopy  of  human  brain  tumors:  assessment  of 
differences between tumor types and its applicability in brain tumor categorization.
Majós C, Alonso J et al 27
This  study  was  done  to  evaluate  the  usefulness  of  proton  magnetic  resonance 
spectroscopy in categorizing brain tumors. Differences in at least two resonances were found 
in all pair wise comparisons of tumor groups except in GBM vs. MET. Large lipid resonance 
was found to be characteristic of GBM and MET, and alanine was characteristic of MEN. 
Significant differences were found between LGA and AA in choline-containing compounds 
and total creatine resonances. These findings correctly classified 84% (21 of 25) tumors in the 
independent test set. Some additional utility was found in glycine/myo-inositol at 3.55 ppm for 
bilateral  differentiation  between  GBM  and  MET.  MRS  provides  useful  information  to 
categorize the most common brain tumors that can be implemented in clinical practice with 
satisfactory results.
AIMS AND OBJECTIVES
The  first  aim  of  this  study  is  to  evaluate  the  value  of  1H-MR  spectroscopy  for 
characterizing brain tumors.
The  second  aim  of  this  study  is  to  analyze  the  usefulness  of  MR  spectroscopy  in 
differentiating the ring enhancing lesions of the brain.
The third aim of this study is to assess the differences between the tumor types and its 
applicability in brain tumor categorization. 
The  fourth  aim  is  to  find  out  the  effect  of  single  voxel  proton  MR  spectroscopic 
findings on treatment decisions.
MATERIALS & METHODS
STUDY PATTERN
This is a prospective study done over a period of two years on patients admitted in the 
Neurosurgery  ward,  Department  of  Neurology  and  Neurosurgery  at  Government  Rajaji 
Hospital, Madurai with intracranial mass lesion for whom MR spectroscopy was taken.
EXCLUSION CRITERIA
Patients with poor quality scans were not taken into the study.
Patients with incomplete dataset for MRS.
Patients with MR Spectroscopy done with Phosphorus or Carbon are excluded from the 
study since this study is done exclusively with Proton MR spectroscopy. 
Patients with congenital cystic lesions.
REASONS FOR EXCLUSION
This study is done exclusively to determine the role of proton MR Spectroscopy in 
differentiating brain tumors. This study does not include congenital cystic lesions for the fact 
that spectroscopy has limited value in congenital cystic lesions.
INCLUSION CRITERIA
Since  our  institution  does  not  have  the  facility  for  MR  spectroscopy,  all  patients 
admitted with MRI films T1W, T2W, T1W contrast and MRS were included in the study.
Patients  examined  only  with  Single  voxel  spectroscopy  were  also  included  in  the 
evaluation of distribution patterns of abnormal spectra.
METHODS
Patient Population
The patients admitted in the Neurosurgical ward in the age group of                   5 - 80 
yrs  with  evidence  suggestive  of  intracranial  space  occupying  lesions  will  be  studied  on 
Magnetic Resonance Spectroscopy on a 1.5 Tesla MR unit. All the patients with mass lesions 
scheduled for surgery were recruited into the study. All  patients  underwent a  preoperative 
workup adapted to the individual’s clinical history and situation. 
CT, MR Imaging, and MR Spectroscopic Measurements 
Preoperative  CT scans  with  contrast  were  obtained  in  all  patients  to  look  for  ring 
enhancement. MRI scan with T1 W, T2 W, T1 with contrast were obtained along with MR 
spectroscopy for characterization of intracranial lesions. Particular interest was shown towards 
contrast enhancing lesions on CT Brain for evaluation under MR spectroscopy.
Some  of  our  patients  had  two  dimensional  chemical-shift  proton  MR spectroscopy 
(multi  voxel  spectroscopy)  that  allows  the  mapping  of  metabolite  concentrations  to  be 
manipulated by computer and superimposed on the image of an abnormality illustrating the 
distribution of such metabolites within the area of intracranial space occupying lesion. Rest of 
them had single voxel spectroscopy owing to the limitation of obtaining MRS from different 
radiological  centers.  Single  voxel  spectroscopy  obtained  from the  mass  lesion,  the  contra 
lateral  normal  brain  parenchyma  and  the  signal  from  the  metabolites  in  the  brain  were 
analyzed. The metabolites that were used for analysis were N-acetyl aspartate (NAA), choline 
(Cho), creatinine (Cr), lactate, alanine, glutamate and lipids. The variations in the Cho/Cr ratio 
and NAA/Cr ratio were noted.
The radiologist’s diagnoses based on MR Spectroscopy were noted. Histopathological 
examinations of the intracranial lesion were studied. In case of suspected tuberculomas where 
HPE was not done, the response to ATT drugs and the resolution of the tuberculoma on follow 
up CT Brain contrast study were taken into account. In our study the emphasis was laid on the 
differentiation of various ring enhancing lesions on CT Brain contrast study with the help of 
MR Spectroscopy. MR Spectroscopy obtained with both PRESS and STEAM were obtained 
for analysis.
Intraoperative Tissue Specimen Collection and Pathological Examination
At the time of surgery biopsy specimens which typically measured 3*3*3 mm3 were 
taken for each patient from the site of intracranial mass lesion. Each tissue sample was then 
taken with small surgical forceps and labeled and handled separately. Biopsy specimens were 
fixed in formalin after removal and were submitted for routine hematoxylin eosin pathologic 
examination.  The  surgical  biopsy  specimens  taken  for  this  study  were  examined  by  a 
pathologist.  The  tumor  grade  assigned  using  the  World  Health  Organization  criteria  for 
classification of brain tumors was used.
Evaluation of MR Spectroscopy
MR  spectroscopic  results  were  evaluated  for  the  distribution  of  pathologic  spectra 
across the lesion and neighboring neuroradiologically normal-appearing tissue and for signal 
ratios in different tumor types. Substances of interest regarding the calculation of signal ratios 
in  different  tumor  types  were  as  follows:  NAA  2.0  ppm;  Cho  3.2  ppm;  creatine  and 
phosphocreatine (Cr) 3.0 ppm; lipid-containing compounds and/or lactate (Lip-Lac), 0.9 to 1.3 
ppm. Signal ratios were calculated for NAA/Cr, Cr/Cho. Only spectra with a clean baseline 
and narrow, visually distinct peaks were used for the metabolite ratio calculation.
The proposed diagnoses and accuracy based on MR spectroscopy  were compared with 
histopathological findings and the usefulness of MRS in differentiating ring enhancing lesions 
of the brain was evaluated.
Statistical Analysis
In this study student t test was used for tumour groups for values of choline, NAA, 
creatine,  myo-inositol,  lipid  peak,  aminoacids,  cho/cr  ratio  and statistical  significance  was 
found. The null hypothesis was rejected when p value was less than 0.05 and the results were 
considered statistically significant.
RESULTS
The data from 50 patients, including spectra and biopsy results, constitute our findings.
The tumor types investigated in our study are shown in table.
Tumour type No of cases
Low grade glioma        (WHO Grade I 
&II)
9
Anaplastic astrocytoma 6
Glioblastoma 4
Metastasis 6
Meningioma 4
Pyogenic abscess 3
Tuberculoma 3
Miscellaneous
  Lymphoma
  Ependymoma
  Medulloblastoma
  Germinoma
 Chordoma
 Multiple sclerosis
 Epidermoid
 Resolving hematoma  
15
2
5
3
2
1
1
1
The value of the observed metabolite peaks along with their ratios were recorded for 
each tumor type. The strongest group differences were seen for choline, choline/creatine ratio, 
alanine and lactate peaks. Presence of decreased myo-inositol levels signified glioblastoma 
differentiating it from anaplastic astrocytoma.
The numerical data are summarized as follows.
Tumour Type Cho Cho/Cr NAA
Low grade Glioma 3.11 3.07 1.16
Anaplastic Astrocytoma 2.98 3.85 0.54
GBM 3.77 5.27 0.86
Metastasis 3.07 4.01 0.41
Meningioma 3.59 8.18 0.22
Pyogenic abscess 0.73 2.26 0.38
Tuberculoma 0.44 1.5 0.30
Control subjects 1.07 1.30 1.93
P value 0.0020 0.0154 0.0012
The results thus obtained were statistically significant
1H MRS metabolic changes observed in the major brain tumours
Major 
Tumor types
Cho Cho/
cr
mI NAA LIP 
Lactate 
peak
AA 
peak
Alanine 
peak
Low grade 
Glioma
↑ ↑ - ↓↔ - - -
Anaplastic ↑ ↑ - ↓↓ ↑ - -
astrocytoma
GBM ↑ ↑ ↓ ↓ ↑↑ ↑ -
Secondaries ↑ ↑ ↓ ↓↓ ↑↑ ↑ -
Meningiomas ↑ ↑ - ↓↓↓ - - ↑↑
Abscess ↓ ↓ ↑ ↓↓↓ ↑ ↑ -
Tuberculoma ↓ ↔ - ↓↓↓ ↑↑ - -
LOW GRADE GLIOMA
Our study had 9 cases of low grade gliomas classified radiologically which includes 
Histopathological WHO grades 1 & 2.  All of these showed an increase in cho and an increase 
in cho/cr ratio. Lipids and myo inositol were absent. NAA showed a mild decrease in value. A 
single case showed the presence of amino acids. All the 9 cases were confirmed with their 
histopathologic  findings.  However,  a  case  was  reported  as  sub  ependymal  giant  cell 
astrocytoma which was later classified as ependymoma based on Histopathological findings.
ANAPLASTIC ASTROCYTOMA
           There were 6 cases of anaplastic astrocytoma in our study. All of them showed an 
increase in cho & cho/cr.  A decrease in NAA was noted. Lipid peak was present in 5/6 cases 
and myo-inositol was absent in all cases. Amino acids were present in 2 cases. All the cases 
were confirmed by histopathology. There was no diagnostic error.
GLIOBLASTOMA
          There were 3 cases of GBM in our study. All of them showed an increase in cho & 
cho/cr. A decrease in NAA was noted. Myoinositol was characteristically decreased in all 3 
cases. Lipid peaks were present in all 3 cases. Amino acids were elevated in 2/3 cases. All 3 
cases were confirmed by histopatology and there was no error in preoperative diagnosis.
There was also a case which was diagnosed as high grade glioma by MRS and was later 
shown to be a ependymoma by histo pathology.
METASTASIS
             There were 6 cases of metastasis in our study. All of them had elevated cho & cho/cr 
and decreased NAA. Lipid lactate peak was noted in all 6 cases. Myo-inositol and amino acids 
were present in 2 cases..
Though  the  MRS  presentation  of  secondaries  is  similar  to  GBM  except  for  the 
consistent low levels of myoinositol in GBM , we did not have any diagnostic confusion since 
in all 6 cases the primary was known prior to MRS.
MENINGIOMAS
             We had 4 cases of meningiomas. All showed decrease in cho, NAA, cho/cr & NAA/cr.  
Alanine peak was characteristically noted in all 4 cases of meningiomas. They are considered 
MRS signatures of meningiomas. All cases were confirmed by histopathology.
ABSCESS
Our study had 3 cases of abscess which showed a decrease in cho, cho/cr, NAA, NAA/
Cr. Amino acids were present in all 3 cases. Lipid lactate and myoinositol were elevated in 2 
cases  each.  Since  we  did  not  encounter  tubercular  abscess,  the  differentiation  between 
tubercular and pyogenic could not be classified.
TUBERCULOMA
Our study had 3 cases of tuberculoma which showed decrease in the levels of cho, 
cho/cr, NAA, NAA/cr. Lipid, lactate was elevated in 2/3 cases. The diagnosis was aided by T2 
central hypointensity characteristic of tuberculomas on MRI. All of them were treated with 
Anti tuberculous therapy and showed resolution of edema, mass and ring enchancement on the 
2nd month.
MISCELLANEOUS
Ependymoma
        There were 5 cases of ependymoma in our study which showed choline peaks with 
reduced creatine. Cases of ependymoma cannot be diagnosed with specific patterns seen on 
MRS and differentiation between ependymoma and medulloblastoma was not distinct  with 
help of SVS.
Lymphoma
2  cases  that  we  had  showed  elevated  choline  and  markedly  reduced  NAA  with 
prominent lipid lactate peaks characteristic for lymphomas.
Summary of results
   Out of the total 50 cases, 44 cases were diagnosed correctly with imaging based on MRI and 
MRS which correlated with histopathology. This gives MRS, a sensitivity of 88% based on our 
study. Out of the 21 cases diagnosed as gliomas, 2 ependymomas were over diagnosed and 
later reclassified, which comes to a diagnostic accuracy of 90.4%. 
However there was no diagnostic confusion in differentiating a tumor from infection 
with the help of MRS which gives it 100% accuracy.
Differentiation  among  various  grades  of  gliomas  were  possible  with  characteristic 
markers on MRS which typically showed decreased myoinositol in GBMs, lipid lactate peaks 
in Anaplastic astrocytomas and with only elevated cho, cho/cr without lipid lactate or changes 
in  myoinositol  levels  in  low  grade  gliomas.   Differentiating  metastasis  from  high  grade 
gliomas was not possible with MRS alone.
                                       DISCUSSION
Spectroscopy is the art of eliciting information without appreciably changing the source 
of information. The information is obtained by perturbing the phenomenon under study and 
then observing its behavior as it attempts to cope with the perturbation. Most spectroscopes 
deal with the interaction of electromagnetic radiation with matter. 
The different frequencies of electromagnetic radiation used as the probes affect matter 
differently  and reflect  different  characteristics  of matter,  e.g.,  X-ray spectroscopy gives  us 
information on the energy changes in the inner electrons of atoms or molecules, visible and 
ultraviolet spectroscopy informs us of the transitions in valence electrons, whereas microwave 
and infrared spectroscopy tells us of molecular and vibration energy transitions of molecules. 
The Heisenberg uncertainty principle, however, ensures that the closer we approach the 
microscopic or quantum world, the less likely it is that our assumption of negligible effect will 
hold. Yet, as the state of the art in biomedical physics improves, increasingly we are realizing 
that to alter the story of any disorder or disease, understanding and intervention must take 
place at the molecular and genetic level.  NMR spectroscopy is one such tool employed to 
understand the biochemical mechanisms of the human body in normal and diseased states. The 
technology  provides  a  basis  to  model  and  interpret  the  macroscopic  clues  manifested  as 
clinical and laboratory findings. The RF region of electromagnetic radiation corresponds to the 
transition  in  energy  levels  of  the  magnetic  states  of  the  atomic  nuclei.  Because  the  same 
nucleus in different molecular structures may show different magnetic states,  MRS can be 
applied to determine molecular structures.
Magnetic  Resonance  Spectroscopy  (MRS)  is  a  proven  and  useful  method  for  the 
evaluation,  assessment  of  severity,  therapeutic  planning,  post-therapeutic  monitoring  and 
follow-up of diseases of the brain and other regions of the body.
In the clinical setting, diagnosis of intracranial mass lesions can be complicated by ambiguous 
neuro radiological  findings,  uncharacteristic  clinical  symptoms or symptom onset.  In these 
cases, additional diagnostic methods are solicited, and MR spectroscopy might, at least when 
dealing with some specific diagnostic problems, be able to increase diagnostic accuracy by 
adding another piece to the diagnostic puzzle. When discussing spectroscopic data of brain 
lesions,  the  significance  of  calculation  of  signal  ratios  and  the  use  of  these  ratios  for 
determining the degree of tumor malignancy or for characterizing histological tumor types or 
subtypes is often stressed.3,10,25,36,44
When  conventional  imaging  by  magnetic  resonance  imaging  (MRI)  or  computed 
tomography (CT)  is  inadequate  to  answer  specific  clinical  questions,  MR Spectroscopy is 
indicated to help in the diagnosis of intracranial lesions. MR Spectroscopy provides a measure 
of brain chemistry. Proton spectroscopy is easier to perform and provides much higher signal-
to-noise  than  either  sodium  or  phosphorus.  Proton  MRS  can  be  performed  within  10-15 
minutes and can be added on to conventional MR imaging protocols. It can be used to serially 
monitor biochemical changes in tumors, stroke, epilepsy, metabolic disorders, infections, and 
neurodegenerative diseases. The MR spectra do not come labeled with diagnoses. They require 
interpretation and should always be correlated with the MR images before making a final 
diagnosis.
Magnetic resonance spectroscopy (MRS) is  a noninvasive technique which provides 
chemical  information  of  metabolites  present  in  living  tissue  and  can  be  used  to  help 
characterize human brain tumors. A histopathological analysis of a biopsy is the present gold 
standard for diagnosis of an abnormal brain mass suspected of being a brain tumor. A biopsy is 
not without risk of morbidity and mortality and cannot be carried out in all instances (e.g., 
brain stem tumors). MRS has the potential to improve the diagnosis of brain tumors, with no 
additional risk to the patient. Several studies have already shown progress in automated pattern 
recognition for brain tumor classification based on MRS data.
Rand et al38 described an analysis of visual inspection of single-voxel spectra at 0.5 T 
with a diagnostic accuracy of 0.96 in distinguishing neoplastic from nonneoplastic lesions. 
Multi voxel methods can be useful if the goal is to obtain a metabolic map of a large lesion or 
brain region. Pruel et al37 were able to correctly classify 104 of 105 tumor spectra. With the use 
of multivoxel techniques, voxels containing viable tumor can be identified. However, unless 
spectral  resolution  is  sacrificed,  the  acquisition  times  for  multivoxel  spectroscopy  can  be 
prohibitively long. 
In single-voxel spectroscopy, the voxel placement is critical to the examination. For this 
reason, we chose to undertake spectroscopy after a contrast enhanced MR imaging series had 
been obtained, as this allows for precise voxel placement over an enhancing region so that 
signal is acquired only from viable tumor tissue. 21,38,43
The optimal pulse sequence parameters for tumor grading are still an issue of debate. 
We have collected MR Spectroscopy done with both STEAM and PULSE sequences and most 
of our collections include single voxel spectroscopy done over the tumor tissue. Optimum 
methods for standardization of in vivo proton spectra are also a matter of debate. The method 
most commonly used is that of taking the ratio of one peak area to another.15,35,42 Another 
approach is to determine carefully the metabolic concentrations in units of mmol/L or weight 
of  brain.  In  all  the  scans  that  we  had  collected,  radiologists  had  chosen  only  peak  ratios 
probably because of the simplicity of the method.
From the observation of our cases, it was studied that MR Spectroscopy has been of 
valuable help in differentiating intracranial lesions. Many studies have been done to validate 
the use of MR Spectroscopy in differentiating brain tumors, its use in infectious lesions, role in 
differentiating metastasis from gliomas, seizures and Alzheimer’s disease. The most important 
use of MR Spectroscopy has been in differentiating recurrent gliomas from radiation necrosis. 
Most  studies  on  MR  Spectroscopy  have  been  concentrated  on  the  use  of  MR 
Spectroscopy in predicting tumor presence and on Neurological disorders like Alzheimer’s, 
Schizophrenia. Only few studies have been done in differentiating ring enhancing lesions on 
CT with MR Spectroscopy which poses a clinical as well as radiological dilemma for the 
Neurosurgeon  regarding  management.  The  most  commonly  encountered  ring  enhancing 
lesions of the brain are high grade gliomas, metastasis, brain abscess, inflammatory lesions 
like tuberculomas, demyelinating diseases, resolving hematomas and cysticercosis.
In our study, we have also used MR Spectroscopy to differentiate grades of tumor. It 
was  postulated  that  elevated  choline  may  reflect  an  increase  in  the  concentration  of  the 
spectroscopically  detectable  metabolites  that  are  precursors  of  membrane  phospholipids 
needed  to  support  the  increased  cell  turnover  in  neoplastic  tissue  reflecting  increased 
cellularity and proliferation, higher membrane turnover or prolongation of T2 relaxation times 
of choline containing compounds. Decreased NAA levels are attributed to the low density of 
neuronal cells. A decreased NAA/creatine ratio is consistent with the replacement of healthy 
neurons by neoplastic cells. Lactate, an end-product of anaerobic glycolysis, is often elevated 
in rapidly growing tumors, in which hypoxic regions may exist and lipid in areas of necrosis. 
In this study, choline was elevated in all gliomas along with increase in choline/creatine ratio.
 In high grade anaplastic astrocytomas, moderate elevation in lipid were seen in all 
cases. In contrast to high grade gliomas, no cases with low grade gliomas showed lipid peak in 
consistent  with finding  from various  published papers.  In  cases  with GBM, all  of   which 
showed prominent lipid peaks along with moderate elevation of myoinositol levels which is in 
accordance  with  some  published  papers  reporting  decreased  levels  of  myoinositol  in 
glioblastoma cases which were confirmed histopathologically. 
Myoinositol (mI), a molecule that is located within astrocytes, is presumed to act as an 
osmolyte, and its concentration is altered in many brain disorders. MI is also involved in the 
activation of protein C kinase. Protein C kinase leads to production of proteolytic enzymes, 
which are found more often in malignant and aggressive primary cerebral tumors. Thus, the 
levels of mI, as seen by magnetic resonance spectroscopy, may be helpful for predicting the 
histological grade of brain tumors. Mauricio Castillo in his paper found that a trend towards 
lower mI/Cr in higher-grade astrocytomas (Anaplastic and GBM) and higher MI/Cr in low-
grade astrocytomas compared with healthy control subjects. 
 Tedeschi et al  used choline as an indicator of the progression of neoplasm and showed 
that  over  a  3-1/2–year  period,  all  progressive  tumors  had  an  increase  in  the  choline 
concentration of over 45%, whereas all stable tumors showed a 35% increase or less. These 
results support our findings that choline and lactate are accurate markers for differentiating 
among tumor grades.
In our study we have 6 cases of metastatic brain disease, all of which had high choline 
levels, high choline/creatine ratio along with prominent lactate and lipid peaks in similarity to 
high grade gliomas. All cases presented with typical irregular ring on contrast enhanced CT 
brain  for  whom  MRS  was  done.  Opstad  et  al  prospectively  recruited  47  patients  with 
pathologically proven glioblastomas or metastases; 7 patients were later excluded due to poor 
quality spectra. The authors focused on the lipid peak-area ratio derived from single-voxel 1H-
MR spectroscopy. They defined this  as the ratio of L1 (the combined alanine,  lactate,  1.4 
macromolecule, and 1.3 lipid peak) to L2 (the combined 0.9 lipid and 0.87 macromolecule 
peaks). Using this ratio, they reported sensitivity and specificity equal to 80% at a threshold 
value of 2.9. He speculated that the difference in lipid profiles may be related to differences of 
membrane structure of infiltrative versus migratory tumor cells or to lipid metabolism.
We  have  four  cases  of  meningiomas,  one  in  intraventricular  location,  one  in 
cerebellopontine  angle  and  the  other  two  were  convexity  meningiomas.  Diagnosis  of 
meningiomas on MRI is usually straight forward unless it is in intraventricular location where 
differential  diagnosis  of  ependymoma,  low grade  gliomas  must  be  considered.   All  cases 
showed alanine peak at 1.47ppm which invert on long TE sequences.
 Alanine peak for meningiomas are considered as signature of meningiomas on MR 
Spectroscopy.  The  presence  of  alanine  may  indicate  that  the  metabolism of  meningiomas 
involves partial oxidation of glutamine rather than glycolysis. All cases had high choline peak 
with low NAA levels representing extramedullary origin of meningiomas. NAA is considered 
a neuronal marker found only in brain. NAA is absent in tumors originating outside the brain 
parenchyma and will only be detected if there is some tissue contamination from the adjacent
brain in the MRS voxel. Significantly, an unusually high ratio of Ala to Cr has been found in 
meningiomas because of the high Ala and low Cr content,  and this is a relatively specific 
finding for meningiomas.
Abscess which typically produce ring enhancement on CT brain were evaluated with 
MR Spectroscopy  as  a  part  of  research  protocol. The  diagnosis  of  pyogenic  abscess  was 
confirmed by aspiration of the pus. The pus was sent for culture and the AFB staining for acid 
fast bacilli. All the three cases of brain abscess we encountered were of pyogenic in nature. In 
our  series  we did not  have tubercular  abscess.  The appearance of  brain abscesses  on MR 
imaging is nonspecific and does not suggest the specific etiologic agent responsible.4,19,22 In all 
cases we had increased amino acid levels with lipid and lactate peaks in two of three cases. 
Pyogenic brain abscesses in MR spectroscopy usually show the presence of amino acids 
at 0.9 ppm and lipid and lactate at 1.3 ppm, with or without the presence of acetate at 1.92 ppm 
and succinate at 2.4 ppm. The amino acids are always observed in pyogenic brain abscesses, 
even when the patient is being treated with antibiotics and repeated aspiration.
Pathologically, the pyogenic brain abscesses contain large amounts of neutrophils and 
proteins, which are released in the necrotic cavity. The breakdown of the neutrophils results in 
the release of large amount of proteolytic enzymes that hydrolyze the proteins into amino acids. 
This is the reason for detecting the amino acids (leucine, isoleucine, and valine) at 0.9 ppm in 
MR spectroscopy in pyogenic brain abscesses. On the other hand, tubercular abscesses teem 
with mycobacteria along with lymphocytes and a small number of neutrophils in the pus and 
necrotic brain tissue.
 The mycobacteria are predominantly composed of lipids. There is a relative lack of 
proteolytic enzymes  in  the  tuberculous  inflammatory  exudates  compared  with pyogenic 
inflammation. Differentiation of tuberculous brain abscess from pyogenic abscess is important 
for  management.  Combined  medical  and  surgical  treatment (repeated  aspirations)  is 
recommended for the care of patients with pyogenic brain abscess, whereas surgical excision 
and antituberculous treatment are the norms for managing tuberculous brain abscess.
We  have  three  cases  of  tuberculomas  in  our  series,  which  were  showing  ring 
enhancement on CT contrast study and MRS showed prominent lipid peaks in all of them with 
corresponding  T2  hypo  intensity  on  MR  imaging16,17,22.  All  cases  were  treated  with  anti-
tuberculous  therapy and showed resolution  of  the  edema,  contrast  enhancement  and mass 
lesion after 4 month period on CT contrast study. Intracranial tuberculomas show prominent 
lipid peaks16,17 due to high lipid content in caseous material. Presence of serine is accepted as a 
distinct  feature  of  tuberculomas.  T2  shortening  along  with  MRS  features  differentiates 
tuberculomas  from other  granulomatous  processes  (fungal  and  sarcoidosis)  and  metastatic 
neoplasms.
Our series  includes one case of tumefactive multiple sclerosis which presented with 
irregular margins with ring like contrast enhancement on CT Brain. MRS done for the lesion 
showed increased choline, choline/creatine ratio, myoinositol and lactate-lipid peak. NAA was 
reduced. Choline is raised in acute plaques. The patient expired within days of treatment. 
Multiple sclerosis is a chronic inflammatory disease of the CNS characterized by focal 
areas  of  demyelination.  The mechanisms behind the  destruction of  myelin  are  still  poorly 
understood.  Reduced NAA is  a  putative  indicator  of  persistent  axonal  damage,  namely  in 
chronic  MS lesions.  Moreover,  choline  containing compounds and myo-inositol  were  both 
found to be elevated within MS plaques, suggesting enhanced membrane turnover.2,7,8,41 The 
rise of lactate within some lesions may correspond to the degree of inflammation, i.e.,  the 
infiltration of macrophages in the acute episodes as seen also in other cerebral diseases. 
Consistent with other studies of increased myoinositol levels in demyelinating and hypo 
myelinating diseases, the present findings of elevated myoinositol most likely represent both 
the  accumulation  of  myelin  breakdown  products  during  acute  phases  and  astrocytosis  in 
demyelinated and remyelinated lesions.
In  our  series,  we  had  one  patient  who  presented  with  focal  seizures,  memory 
disturbance and headache with frontal release signs on examination. CT scan contrast study 
revealed a ring enhancing lesion in the dominant frontal region. MRS showed reduction of all 
metabolites.  Reduction  of  all  metabolites  will  be  seen  in  hematomas  and  can  be  used  to 
distinguish it  from neoplastic lesions. Follow up CT brain after 2 months showed resolution of 
the hematoma. 
We also had two cases of lymphoma which showed increased choline and prominent 
lipid lactate peaks.  The spectroscopic appearance of lymphoma is similar to that of primary 
high-grade  astrocytoma  and  metastases.5 MR  spectroscopy  shows  a  marked  elevation  of 
choline and lipids and a significant reduction in creatine and NAA. MR spectroscopy is helpful 
in assessing the response of lymphoma to treatment; successfully treated lymphoma shows 
progressive decrease in choline and lipids.
CONCLUSION
Proton MR spectroscopy (1H MRS) has been recognized as a safe diagnostic technique 
that can improve the noninvasive categorization of brain disorders and help in differentiating 
ring enhancing lesions seen on CT brain contrast study.
We have shown that  specific  metabolites  are  of  diagnostic  value  in  the  division of 
tumors into three categories. Specifically, the lactate can be used to differentiate GBMs and 
anaplastic astrocytomas from low grade tumors. GBM can be identified in this group by high 
values of Lip 0.9 and Lip 1.3. These two broad resonances have been ascribed to necrotic 
regions  in  spectra  and  indicate  a  high  grade  of  malignancy. The  levels  of  choline, 
choline/creatine, NAA/creatine can be used to distinguish high-grade from low grade tumors. 
We found lower myoinositol in higher-grade tumors [GBM.].
Increase in alanine, defined as an inverted doublet centered at 1.47 ppm, has been found 
to be a consistent and relatively specific finding for meningiomas.
Metastases are high-grade brain lesions in which presence of necrosis, represented by 
broad resonances centered at 0.90 and 1.30 ppm were noted. Our study confirms a significant 
increase of these lipid resonances in metastasis, in contrast with lower-grade tumors. We did 
not find any statistically significant difference between GBM and metastasis in the resonances 
defined in our study; accordingly,  we considered them as a single group for  classification 
purposes.
The conglomerate  ring  enhancement  suggesting  inflammatory  rather  than  neoplastic 
along  with  central  hypo  intensity  on  T2  with  prominent  lipid  peak  is  characteristic  for 
tuberculomas.
The  appearance  of  brain  abscesses  on  MR  imaging  was  nonspecific and  does  not 
suggest the specific etiologic agent responsible. Pyogenic brain abscesses on MR spectroscopy 
showed the presence of amino acids lipids and lactate. The amino acids were always observed 
in pyogenic brain abscesses.
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